Neil Woodford
Top performing UK-based investor Neil Woodford has published his full investment portfolio, revealing that biopharmas Alkermes, BTG and Prothena join Sanofi, Novartis, GSK, Roche and AstraZeneca on the list of companies his fund backs.
Other biopharmas on Woodford’s investment list include: e-Therapeutics,Vernalis, ReNeuron, 4D Pharma, Oxford Pharmascience, Retroscreen Virology, NetScientific and Circassia.